Sympathetic Paraganglioma

subtype

Identifier: CI-CAN-00004047
Entity page: /cancer/sympathetic-paraganglioma ↗
Edges: 154

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Sympathetic Paraganglioma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 27show all (up to 200)
→ investigated in trials for	Temozolomidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Sympathetic Paraganglioma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall molecule

Sympathetic Paraganglioma studied in …STUDIED_INderived10 of 127show all (up to 200)
→ studied in	NCT00004847Phase 1 · recruiting Diagnosis of Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07743138Phase 2 · not yet recruiting STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL) · condition mapped ALIAS · 127 trials mapped (42 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04394858Phase 2 · active not recruiting Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer · condition mapped CURATED_BROADER · 127 trials mapped (42 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02402244recruiting Project: Every Child for Younger Patients With Cancer · condition mapped ONTOLOGY_EXACT · 127 trials mapped (42 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03206060Phase 2 · recruiting Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma · condition mapped ALIAS · 127 trials mapped (42 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06427798Phase 1/Phase 2 · recruiting Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy · condition mapped ALIAS · 127 trials mapped (42 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06377033NA · recruiting Using the EHR to Advance Genomic Medicine Across a Diverse Health System · condition mapped ALIAS · 127 trials mapped (42 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03015844available A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma · condition mapped ALIAS · 127 trials mapped (42 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07714551Phase 2 · not yet recruiting Zanzalintinib in Unresectable and Progressive MPGGs · condition mapped ALIAS · 127 trials mapped (42 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02721732Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic · condition mapped CURATED_BROADER · 127 trials mapped (42 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains